CYP2C19 is primarily a drug-metabolizing enzyme, known for processing medications like clopidogrel and proton pump inhibitors. A direct role in fertility is not scientifically established. No robust human studies demonstrate that CYP2C19 variants affect conception or reproductive outcomes. Theoretically, altered enzyme activity could influence hormone or toxin metabolism, but this remains speculative. Evidence is therefore classified as unclear. Consumers should not rely on CYP2C19 test results for fertility decisions. For fertility concerns, medical evaluations (hormone panels, cycle analysis, semen analysis) are far more relevant than a single gene. MyBody-X does not offer specific analysis linking CYP2C19 to fertility; its tests focus on metabolism, nutrition, and general health.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-425e8f42732a647a5b0faa0e